BioAtla (BCAB) Debt Ratio (2020 - 2021)

BioAtla's (BCAB) quarterly Debt Ratio came in at 0.0 in Q2 2021, up 5.71% quarter-over-quarter from 0.0 in Q1 2021.

BioAtla (BCAB) Debt Ratio (2020 - 2021) Analysis & Trends

BioAtla's Debt Ratio history runs 2 years deep, the most recent figure standing at 0.0 for Q2 2021.

On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.0 in Q2 2021; TTM through Jun 2021 was 0.0, a N/A change from a year earlier, with the FY2020 full-year figure at 0.0, changed N/A from the prior year.
Debt Ratio climbed to 0.0 in Q2 2021 per BCAB's latest filing, from 0.0 in the prior quarter.
Across five years, Debt Ratio topped out at 0.0 in Q2 2021 and bottomed at 0.0 in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	1.41
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.11
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.05
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	BioAtla	5.74 Mn	5.74 Mn	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2021	0.00
Mar 31, 2021	0.00
Dec 31, 2020	0.00